The projected fair value for GeneDx Holdings is US$253 based on 2 Stage Free Cash Flow to Equity GeneDx Holdings' US$152 share price signals that it might be 40% undervalued The US$165 analyst price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback